Raveneau, Magali
Guerrini-Rousseau, Léa
Levy, Raphael
Roux, Charles-Joris
Bolle, Stéphanie
Doz, François
Bourdeaut, Franck
Colas, Chrystelle
Blauwblomme, Thomas
Beccaria, Kevin
Tauziède-Espariat, Arnault
Varlet, Pascale
Dufour, Christelle
Grill, Jacques
Boddaert, Nathalie
Dangouloff-Ros, Volodia https://orcid.org/0000-0003-1260-5886
Article History
Received: 10 February 2024
Revised: 27 March 2024
Accepted: 4 May 2024
First Online: 9 July 2024
Compliance with ethical standards
:
: The scientific guarantor of this publication is V.D.R.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise.
: Parental agreement on behalf of the patients was prospectively obtained to perform molecular testing of tumor samples. Parental consent for MR imaging analysis was waived for this retrospective observational study.
: Ethical committee approval was obtained to study the multimodal imaging of children’s brain tumors (EDRACT 2014-A-00541-46).
: 26/30 CMMRD patients have been previously published with clinical or biological descriptions, but without in-depth imaging analysis (see Supplementary Table with related published articles).
: